To be or not to be NKT: Natural killer T cells in the liver
暂无分享,去创建一个
[1] S. Tahir,et al. Cutting Edge: A Major Fraction of Human Bone Marrow Lymphocytes Are Th2-Like CD1d-Reactive T Cells That Can Suppress Mixed Lymphocyte Responses1 , 2001, The Journal of Immunology.
[2] S. Balk,et al. Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells , 1997, The Journal of experimental medicine.
[3] B. Graham,et al. NK T Cells Contribute to Expansion of CD8+ T Cells and Amplification of Antiviral Immune Responses to Respiratory Syncytial Virus , 2002, Journal of Virology.
[4] A. Diehl,et al. Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system. , 2002, Gastroenterology.
[5] M. Ishigami,et al. The roles of intrahepatic Vα14+ NK1.1+ T cells for liver injury induced by Salmonella infection in mice , 1999 .
[6] V. Barnaba,et al. Dynamics of intra‐hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis , 1998, European journal of immunology.
[7] S. Snapper,et al. Cd1-Reactive Natural Killer T Cells Are Required for Development of Systemic Tolerance through an Immune-Privileged Site , 1999, The Journal of experimental medicine.
[8] G. Mayrhofer,et al. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. , 2003, Journal of immunology.
[9] N. Afdhal,et al. Hepatic CD1d Expression in Hepatitis C Virus Infection and Recognition by Resident Proinflammatory CD1d-Reactive T Cells1 , 2004, The Journal of Immunology.
[10] D. Doherty,et al. NKT Cells from Normal and Tumor-Bearing Human Livers Are Phenotypically and Functionally Distinct from Murine NKT Cells , 2003, The Journal of Immunology.
[11] M. Taniguchi,et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. , 1997, Science.
[12] M. Jackson,et al. Peptide binding and presentation by mouse CD1. , 1995, Science.
[13] A. Harris,et al. NKT Cells Enhance CD4+ and CD8+ T Cell Responses to Soluble Antigen In Vivo through Direct Interaction with Dendritic Cells 1 , 2003, The Journal of Immunology.
[14] R. Good,et al. An NK1.1+ CD4+8- single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor V beta family. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Snapper,et al. Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus. , 1999, Journal of immunology.
[16] S. Tahir,et al. CD1d‐reactive T‐cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus , 2001, Journal of leukocyte biology.
[17] T. Kosaka,et al. Association of CD8+ natural killer T cells in the liver with neonatal tolerance phenomenon. , 2002, Transplantation.
[18] Hiroshi Sato,et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. , 1997, Science.
[19] D. Pellicci,et al. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. , 2002, Blood.
[20] P. Klenerman,et al. Virus‐specific CD8+ T lymphocytes within the normal human liver , 2004, European journal of immunology.
[21] J. Yewdell,et al. CD1 recognition by mouse NK1+ T lymphocytes. , 1995, Science.
[22] A. Diehl,et al. Altered hepatic lymphocyte subpopulations in obesity‐related murine fatty livers: Potential mechanism for sensitization to liver damage , 2000, Hepatology.
[23] F. Callea,et al. Production of Profibrotic Cytokines by Invariant NKT Cells Characterizes Cirrhosis Progression in Chronic Viral Hepatitis1 , 2004, The Journal of Immunology.
[24] L. Kaer,et al. Critical contribution of liver natural killer T cells to a murine model of hepatitis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] Takashi Yamamura,et al. Functionally Distinct Subsets of CD1d-restricted Natural Killer T Cells Revealed by CD1d Tetramer Staining , 2002, The Journal of experimental medicine.
[26] L. Lanier. On guard—activating NK cell receptors , 2001, Nature Immunology.
[27] S. Balk,et al. Cutting Edge: Compartmentalization of Th1-Like Noninvariant CD1d-Reactive T Cells in Hepatitis C Virus-Infected Liver , 2002, The Journal of Immunology.
[28] S. Balk,et al. CD161 (NKR-P1A) Costimulation of CD1d-dependent Activation of Human T Cells Expressing Invariant Vα24JαQ T Cell Receptor α Chains , 1998, The Journal of experimental medicine.
[29] J. Reimann,et al. NKT Cells Provide Help for Dendritic Cell-Dependent Priming of MHC Class I-Restricted CD8+ T Cells In Vivo 1 , 2003, The Journal of Immunology.
[30] M. Smyth,et al. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. , 2001, International immunology.
[31] H. Watanabe,et al. Antimetastatic effect of NK1+ T cells on experimental haematogenous tumour metastases in the liver and lungs of mice , 1997, Immunology.
[32] F. Leithäuser,et al. Activating Immunity in the Liver. I. Liver Dendritic Cells (but Not Hepatocytes) Are Potent Activators of IFN-γ Release by Liver NKT Cells1 , 2001, The Journal of Immunology.
[33] M. Kronenberg,et al. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. , 1998, Journal of immunology.
[34] G. Giaccone,et al. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] S. Balk,et al. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain , 1993, The Journal of experimental medicine.
[36] S. Ichimiya,et al. Structural analysis of the rat homologue of CD1. Evidence for evolutionary conservation of the CD1D class and widespread transcription by rat cells. , 1994, Journal of immunology.
[37] L. Kaer,et al. Activation of hepatic NKT cells and subsequent liver injury following administration of α‐galactosylceramide , 2000, European journal of immunology.
[38] T. Juji,et al. Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. , 2004, Blood.
[39] L. Kaer,et al. NKT cells: what's in a name? , 2004, Nature Reviews Immunology.
[40] L. Bry,et al. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection , 2003, Nature Immunology.
[41] P. Klenerman,et al. Frequency and Phenotype of Circulating Vα24/Vβ11 Double-Positive Natural Killer T Cells during Hepatitis C Virus Infection , 2003, Journal of Virology.
[42] T. Juji,et al. Therapeutic activation of Vα24^+Vβ11^+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity , 2004 .
[43] T. Delovitch,et al. Regulatory lymphocytes: Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity , 2003, Nature Reviews Immunology.
[44] J. Trapani,et al. Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells , 2000, The Journal of experimental medicine.
[45] M. Kaplan,et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. , 2002, Gastroenterology.
[46] D. Doherty,et al. Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection. , 2002, Journal of hepatology.
[47] M. Brenner,et al. Diverse TCRs recognize murine CD1. , 1999, Journal of immunology.
[48] A. Wendel,et al. Concanavalin A hepatotoxicity in mice: Tumor necrosis factor–mediated organ failure independent of caspase‐3–like protease activation , 1999, Hepatology.
[49] M. Siomos,et al. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. , 2003, Immunity.
[50] A. Dautry‐Varsat,et al. Distinct Subsets of CD1d-restricted T Cells Recognize Self-antigens Loaded in Different Cellular Compartments , 1999, The Journal of experimental medicine.
[51] G. Fantuzzi,et al. Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[52] S. Huber,et al. Role of CD1d in Coxsackievirus B3-Induced Myocarditis 1 , 2003, The Journal of Immunology.
[53] H. Fujiwara,et al. A Novel Function of Vα14+CD4+NKT Cells: Stimulation of IL-12 Production by Antigen-Presenting Cells in the Innate Immune System , 1999, The Journal of Immunology.
[54] N. Hayashi,et al. CD1d‐mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver , 2003, International journal of cancer.
[55] R. Locksley,et al. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. , 2002, Immunity.
[56] O. Shibolet,et al. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen‐pulsed dendritic cells , 2003, International journal of cancer.
[57] G. Bubley,et al. Loss of IFN-γ Production by Invariant NK T Cells in Advanced Cancer1 , 2001, The Journal of Immunology.
[58] O. Lantz,et al. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans , 1994, The Journal of experimental medicine.
[59] M. Nozue,et al. Impaired Proliferative Response of Vα24 NKT Cells from Cancer Patients Against α-Galactosylceramide1 , 2002, The Journal of Immunology.
[60] L. Kaer,et al. Cutting Edge: Critical Role of NK1+ T Cells in IL-12-Induced Immune Responses In Vivo , 1998, The Journal of Immunology.
[61] K. Tsuneyama,et al. Increased cd1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis , 1998, Hepatology.
[62] L. Teyton,et al. Distinct Functional Lineages of Human Vα24 Natural Killer T Cells , 2002, The Journal of experimental medicine.
[63] A. Chott,et al. Structure and Function of the CD1 Family of MHC‐like Cell Surface Proteins , 1995, Immunological reviews.
[64] S. Seki,et al. Mechanisms of the Antimetastatic Effect in the Liver and of the Hepatocyte Injury Induced by α-Galactosylceramide in Mice , 2001, The Journal of Immunology.
[65] K. Tsuneyama,et al. Accumulating CD57 + CD3 + natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis , 2003, Liver international : official journal of the International Association for the Study of the Liver.
[66] M. Neurath,et al. Disruption of T helper 2-immune responses in Epstein–Barr virus-induced gene 3-deficient mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[67] A. Ohta,et al. The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells , 1999, The Journal of experimental medicine.
[68] S. Toyabe,et al. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. , 1997, Journal of immunology.
[69] H. Fujiwara,et al. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[70] Hiroshi Sato,et al. Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors , 1997 .
[71] A. Fersht,et al. Human CD1d–glycolipid tetramers generated by in vitro oxidative refolding chromatography , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[72] D. Doherty,et al. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. , 1999, Journal of immunology.
[73] L. Teyton,et al. In Vivo Identification of Glycolipid Antigen–Specific T Cells Using Fluorescent Cd1d Tetramers , 2000, The Journal of experimental medicine.
[74] M. Alegre,et al. Tissue distribution, regulation and intracellular localization of murine CD1 molecules. , 1998, Molecular immunology.
[75] H. Nagawa,et al. CD8+NKR‐P1A+ T cells preferentially accumulate in human liver , 1999, European journal of immunology.
[76] S. Park,et al. Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.
[77] 河野 鉄. CD1d-restricted and TCR-mediated activation of V α14 NKT cells by glycosylceramides , 2000 .
[78] R. Steinman,et al. Activation of Natural Killer T Cells by -Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein , 2003 .
[79] Michael B Brenner,et al. CD1: antigen presentation and T cell function. , 2004, Annual review of immunology.
[80] H. Macdonald,et al. Selective Bystander Proliferation of Memory CD4+ and CD8+ T Cells Upon NK T or T Cell Activation , 2000, The Journal of Immunology.
[81] P. Mannon,et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. , 2004, The Journal of clinical investigation.
[82] M. Dhodapkar,et al. A Reversible Defect in Natural Killer T Cell Function Characterizes the Progression of Premalignant to Malignant Multiple Myeloma , 2003, The Journal of experimental medicine.
[83] S. Kaufmann,et al. Cutting edge: anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-beta 2 and Th1 cytokines and ameliorates listeriosis in mice. , 1999, Journal of immunology.
[84] K. Hatakeyama,et al. Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation , 2000, Hepatology.
[85] I. N. Crispe,et al. Hepatic T cells and liver tolerance , 2003, Nature Reviews Immunology.
[86] M. Nozue,et al. Impaired proliferative response of V alpha 24 NKT cells from cancer patients against alpha-galactosylceramide. , 2002, Journal of immunology.
[87] R. Seeger,et al. Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells1 , 2001, The Journal of Immunology.
[88] H. Macdonald,et al. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. , 1999, Journal of immunology.
[89] H. Fujiwara,et al. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. , 1999, Journal of immunology.
[90] K. Tadokoro,et al. Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner. , 1999, Human immunology.
[91] S. Nuti,et al. CD1d-restricted Help To B Cells By Human Invariant Natural Killer T Lymphocytes , 2003, The Journal of experimental medicine.
[92] N. Fazilleau,et al. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor β repertoire and small clone size , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[93] D. Doherty,et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. , 1998, Journal of hepatology.
[94] F. Chisari,et al. Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in Vivo , 2000, The Journal of experimental medicine.
[95] G. Fantuzzi,et al. Leptin deficiency, not obesity, protects mice from Con A‐induced hepatitis , 2002, European journal of immunology.
[96] S. Küsters,et al. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. , 1996, Gastroenterology.
[97] H. S. Kim,et al. The role of CD1d in the immune response against Listeria infection. , 2004, Cellular immunology.
[98] Y. Koezuka,et al. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. , 1999, Journal of immunology.
[99] Taniguchi,et al. Differences in the Ligand Specificity between CD1d‐Restricted T Cells with Limited and Diverse T‐Cell Receptor Repertoire , 2000, Scandinavian journal of immunology.
[100] H. Mochizuki,et al. Decrease of CD56+T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma , 2000, Hepatology.
[101] A. Tzakis,et al. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody. , 1998, Human immunology.
[102] K. Tadokoro,et al. Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner , 1999 .
[103] S. Riddell,et al. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. , 2001, Nature immunology.
[104] S. Porcelli,et al. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. , 1999, Annual review of immunology.
[105] Y. Iwakura,et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[106] D. Pellicci,et al. CD1d-Restricted NKT Cells: An Interstrain Comparison1 , 2001, The Journal of Immunology.
[107] M. Kronenberg,et al. CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution , 1998, The Journal of experimental medicine.
[108] 石上 雅敏. The roles of intrahepatic Vα14[+] NK1.1[+] T cells for liver injury induced by Salmonella infection in mice , 1999 .
[109] M. Smyth,et al. NKT cells are phenotypically and functionally diverse , 1999, European journal of immunology.